- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.04. | Myndtec Inc: Myndtec receives U.S. patent for UHN-licensed tech | 1 | Stockwatch | ||
| 09.04. | MyndTec Inc.: MyndTec Brain Activity Technology Licensed from UHN Awarded U.S. Patent | 207 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - April 9, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, today announced that... ► Artikel lesen | |
| 20.03. | Myndtec Inc: Myndtec closes $135,160 fourth tranche of financing | 1 | Stockwatch | ||
| 20.03. | MyndTec Inc. Completes Fourth Tranche of Non-Brokered Private Placement | 278 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - March 19, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 14.02. | Myndtec Inc: Myndtec closes $134,310 third tranche of financing | 1 | Stockwatch | ||
| 14.02. | MyndTec Inc. Completes Third Tranche of Non-Brokered Private Placement | 332 | Newsfile |
Mississauga, Ontario--(Newsfile Corp. - February 13, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging player in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 23.01. | Myndtec Inc: Myndtec receives statement of claim for $715,201 | 1 | Stockwatch | ||
| 22.01. | MyndTec Inc. Receives Statement of Claim and Intends to Defend Itself | 349 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - January 22, 2024) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a medical technology company, today announced it has been served with a statement... ► Artikel lesen | |
| 21.12.23 | Myndtec Inc: Myndtec closes $133,068 second tranche of placement | 2 | Stockwatch | ||
| 21.12.23 | MyndTec Inc. Completes Second Tranche of Non-Brokered Private Placement | 462 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - December 20, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 04.11.23 | MyndTec Inc. Completes Non-Brokered Private Placement | 491 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - November 3, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 14.10.23 | MyndTec Inc. Announces Non-Brokered Private Placement | 455 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - October 13, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 18.08.23 | MyndTec Inc. Announces Debt Settlement Agreement with a Director | 413 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - August 17, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 14.07.23 | MyndTec Inc. Closes Previously Announced Shares for Debt Transaction | 457 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - July 13, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 07.07.23 | MyndTec Inc. Announces Debt Settlement Agreement | 389 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - July 6, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 30.05.23 | MyndTec Inc. Announces Strategic Consulting Agreement with Rehabilitation Technology Industry Expert | 681 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - May 30, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is thrilled to unveil... ► Artikel lesen | |
| 27.05.23 | MyndTec Inc. Announces Grant of Stock Options in Connection with a Consulting Agreement | 561 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - May 26, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging force in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen | |
| 26.05.23 | MyndTec Inc. Completes Non-Brokered Private Placement | 463 | Newsfile | Mississauga, Ontario--(Newsfile Corp. - May 25, 2023) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 51,90 | +1,37 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| FRESENIUS | 27,950 | -0,07 % | Fresenius mit Verkauf: Wachstum des Kerngeschäfts im Fokus - Aktie zieht weiter an | Fresenius kommt bei seiner Neuausrichtung weiter voran. Wie der Gesundheitskonzern am Donnerstagabend mitgeteilt hat, soll das Vamed-Reha-Geschäft veräußert werden. Fresenius werde aber ein Drittel... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,260 | -2,34 % | Kursgewinne für die Aktie von Fresenius Medical Care (38,13 €) | Im deutschen Wertpapierhandel liegt der Anteilsschein von Fresenius Medical Care aktuell im Plus. Das Wertpapier kostete zuletzt 38,13 Euro. Freuen können sich gegenwärtig die Aktionäre von Fresenius... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 64,31 | +4,16 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| CARL ZEISS MEDITEC | 97,80 | +0,46 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 3,330 | -84,91 % | Mobile-health Retreats on Opening New Pharmacy | ||
| RXSIGHT | 61,68 | +3,44 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| ATRICURE | 20,890 | -5,99 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| GERRESHEIMER | 102,00 | +0,39 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen | EQS-News: Gerresheimer AG
/ Schlagwort(e): Vertrag/Beteiligung/Unternehmensbeteiligung
Gerresheimer schließt Partnerschaft mit RxCap für vernetzte Adhärenz-Lösungen
29.04.2024... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,740 | +1,79 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,500 | +3,98 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CASTLE BIOSCIENCES | 24,330 | +6,52 % | Castle Biosciences Reports First Quarter 2024 Results | FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results... ► Artikel lesen | |
| ADAPTHEALTH | 10,260 | -0,87 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 6,630 | +26,05 % | Alignment Healthcare Reports First Quarter 2024 Results | Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to... ► Artikel lesen | |
| MIMEDX | 7,370 | -1,73 % | MiMedx Group, Inc: MIMEDX Announces First Quarter 2024 Operating and Financial Results | Net Sales of $85 Million Grew 18% Year-Over-Year for the First Quarter First Quarter GAAP Net Income was $9 Million First Quarter Adjusted EBITDA of $19 Million, or 22% of Net Sales Management... ► Artikel lesen |
Das Unternehmen MYNDTEC INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
